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Abstract
Carcinomas arise in a complex microenvironment consisting of multiple distinct epithelial lineages surrounded by a variety
of stromal cell types. Understanding cancer etiologies requires evaluating the relationship among cell types during disease
initiation and through progression. Genetically engineered mouse (GEM) models facilitate the prospective examination of
early oncogenic events, which is not possible in humans. Since most solid tumors harbor aberrations in the RB network, we
developed an inducible GEM approach for the establishment and assessment of carcinoma initiation in a diverse range of
epithelial tissues and subtypes upon inactivation of RB-mediated tumor suppression (RB-TS). The system allows
independent assessment of epithelial subtypes that express either cytokeratins (K) 18 or 19. By Cre-dependent expression of
a protein that dominantly inactivates RB and functionally redundant proteins p107 and p130, neoplasia could be initiated in
either K18 or K19 expressing cells of numerous tissues. By design, because only a single pathway aberration was
engineered, carcinomas developed stochastically only after long latency. Hence, this system, which allows for directed cell
type-specific carcinoma initiation, facilitates further definition of events that can progress neoplasms to aggressive cancers
via engineered, carcinogen-induced and/or spontaneous evolution.
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Introduction
Malignant cancers evolve through mechanisms of selective
growth, survival, and invasive properties in a diverse microenvi-
ronment. Thus, cancers are heterogeneous with a complex
constituency of multiple cell types. Genetically engineered mouse
(GEM) models provide a powerful approach to assess both cause/
effect relationships and cell type susceptibility. Over the past few
decades, progress has been made in identifying molecular
aberrations that can contribute to tumorigenesis, thus offering
insight into potential causal mechanisms and therapeutic targets.
However, since many events have been engineered together and
often don’t initiate disease, relatively few studies have explored the
etiology of tumor evolution from initiation through progression to
advanced disease. Here, we sought to develop ‘‘GEM cancer-
initiator’’ models that could be induced to initiate tumorigenesis in
a wide variety of epithelial tissues and in distinct subtype
compartments for further use in defining tissue and cell-specific
mechanisms for carcinoma progression.
Cell subtypes of an epithelium can be characterized by
specifically paired cytokeratin (K) expression profiles [1–3].
Cytokeratins are cytoskeleton protein intermediate filaments
assembled from heterodimeric subunits of acidic type I (K9–
K28) and basic type II (K1–K8, and K71–K80) proteins [4]. K18,
usually paired with K8, is the first keratin expressed at the eight-
cell stage of mouse development [5,6], followed by K19 and K7
[7]. However, K19, the smallest known acidic keratin, has no
known basic type II keratin partner. Although both K18 and K19
are expressed in simple epithelia, they are differentially expressed
in subtypes of some epithelia (e.g. K18 in umbrella cells and K19
in basal and intermediate cells of urothelium [2,3,8]). Therefore,
distinct keratin expression patterns can be utilized as the basis for
targeting tumor initiation events to specific epithelial subtypes.
Retinoblastoma 1 (RB) is a negative regulator of proliferation in
the eukaryotic cell cycle, particularly during cellular differentiation
[9], and the RB pathway plays a critical role in tumorigenesis.
Aberrant RB pathway activity, resulting from defects in RB itself,
CDKN2A, CCND1, or CDK4, is observed in most solid human
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cancers [10]. In the few cancer types wherein early human tissue is
routinely accessible, such aberrations are often present, suggesting
a role in initiation [11–15]. However, in some cases, the first
association of RB pathway aberration is apparent in more
advanced cancer, arguing a role in progression [16]. Indeed,
cause and effect relationships likely depend on multiple variables,
including the cell and tissue of origin and the stochastic order of
causal events, emphasizing the need for model systems to
determine plausible roles in disease etiology. Because of functional
redundancy among RB and its family members p107 and p130 in
most murine cell types [17–20], we have used a dominant
inactivating protein, T121, to inactivate RB tumor suppression
(RB-TS) in the mouse [21–25]. T121 is derived from the N-
terminal 121 amino acids of Simian Virus 40 (SV40) large T
antigen, which evolved to inactivate the RB-mediated cell cycle
brake. When directed by tissue specific promoters in transgenic
mice, T121 is sufficient to initiate tumorigenesis in prostate [26],
mammary [27], ovarian [28] and choroid plexus [29] epithelial
cells, as well as in central nervous system astrocytes [30,31]. The
initiation phenotype is dependent on the T121 RB/p107/p130
binding site as demonstrated by point mutagenesis [32]. In each
case examined thus far, initiation is associated with aberrant
proliferation accompanied by apoptosis, and tumor progression
has been driven by engineered and/or stochastic aberration of
specific cancer-associated molecular networks [28,31,33].
Here, we describe transgenic mouse lines in which RB-TS
inactivation can be induced in either K19 or K18-expressing
epithelial subtypes in a Cre recombinase-dependent fashion.
Transgenic lines were established in which Cre-conditional
expression of T121 was driven under cytokeratin18 or 19
transcriptional control using bacterial artificial chromosome
(BAC) transgenes that retain endogenous expression patterns in
diverse tissues. Thus, a single strain for each subtype can be used
to drive cancer initiation tissue-specifically via organ-specific Cre
expression after germline or somatic introduction of a Cre
transgene. By selective inactivation of RB-TS in K18- or K19-
expressing cells, we demonstrate the broad utility of these ‘‘cancer-
initiator’’ mice in mechanistic studies of cancer development and
show roles for RB-TS inactivation and epithelial subtype




This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by Animal Care and Use Committee
(ACUC) of UNC-Chapel Hill (Permit Number: 04-232.0), and
National Cancer Institute (NCI)-Frederick (Permit Number: 11-
030). All animals in this study were euthanized per the ‘‘Guidelines
For The Euthanasia of Mouse and Rat Fetuses and Neonates’’ as
defined by the ACUC of UNC-Chapel Hill and NCI-Frederick to
minimize pain and suffering.
Generation of Subtype-specific Keratin-directed BAC
Transgenic Mice
A floxed eGFP stop T121 cassette (transgene cassette, Figure 1A)
was derived from the MFT121 construct [34]. T121 is comprised of
the first 121 amino acids (aa) of the SV40 large T antigen followed
by 11 missense amino acids resulting from a 31 bp deletion. The
transgene cannot express small t antigen due to a second deletion
that removes its splice acceptor site [35]. T121 inactivates RB and
family members p107 and p130 and does not contain the p53 and
p300 inactivating domain [36]. The RPCI-22 mouse genomic
DNA library was screened using specific probes designed for K18
(Krt1-18 on chromosome 15) and K19 (Krt1-19 on chromosome
11) via the RPCI BAC screening service (Roswell Park Cancer
Institute, NY). Positive clones were used for recombineering-
Figure 1. Scheme of transgene constructs and copy number. A. Transgene cassette: An eGFP stop cassette was flanked by loxP sites and the
T121 gene was placed downstream. B. Keratin bacterial artificial chromosome (BAC) transgene constructs: a transgene cassette (A) was inserted
upstream of the start ATG codon in exon 1 of K18 (derived from mouse chromosome (Chr.) 15) and of K19 (derived from mouse Chr 11) in BACs using
recombineering. The insertion site for the loxP-eGFP-stop-loxP-T121 cassette is indicated by a dashed ‘‘V’’. Representative genes downstream of
keratin genes are indicated in boxes. Solid black bars indicate exons (E). C. Transgene copy number per diploid genome was determined by qPCR.
doi:10.1371/journal.pone.0080459.g001
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directed insertion [37,38] of floxed eGFP-stop-T121 cassettes into
exon 1 start codons of K18 and K19. BAC DNA was purified
(MTR Scientific, Ijamsville, MD) and injected into fertilized eggs
harvested from a B6D2F1 (JAX Laboratory, Bar Harbor, Maine)
cross at a concentration of 4 ng/ul without linearization as
described [39]. Resulting and subsequent generations of transgenic
mice were identified by PCR amplification of a 215-bp fragment
using primers 59 GAATCTTTGCAGCTAATGGACC 39 and 59
GCATCCCAGAAGCTCCAAAG 39 and digit- or ear-derived
genomic DNA as template. The cycling profile was: 94uC, 2
minutes; followed by 35 cycles of 94uC, 20 seconds; 62uC, 45
seconds; 72uC, 45 seconds; and a final incubation of 72uC, 2
minutes. Mouse lines were maintained by mating with wild type
B6D2F1 mice and therefore are designated as B6;D2-
Tg(K18GT121)Tvd (TgK18GT121) and B6;D2-Tg(K19GT121)Tvd
(TgK19GT121).
Transgenic Breeding Strategies
TgK18GT121 and TgK19GT121 mice were crossed to b-actin Cre
mice (FVB or C57BL6/NCr background), and TgK19GT121 to
K19CreER mice (C57BL/6 background, provided by Dr. Guo-
qiang Gu at Vanderbilt University) [40] to determine the tumor
initiation capability upon RB-TS inactivation in K19 and K18
subtypes.
Transgene Copy Number Determination
Tail genomic DNA was extracted using Qiagen DNeasy Blood
and Tissue kit, and quantitative real time PCR was used to detect
transgene copy numbers. PCR amplifications were performed in
96-well plates in the ABI 7500 sequence detector. 30 ul samples
included 10 ul (50 ng) genomic DNA sample and 20 ul PCR
reaction mixture. Amplification was with 10 minutes at 94uC
followed by 40 cycles of 15 seconds at 94uC and 1 minute at 60uC.
Primers and probe sequences for T121 gene were: forward: 59 CTT
TGC AGC TAA TGG ACC TTC 39, reverse: 59 TGC CTT
TCT CAT CAG AGG AAT 39, and probe: 59 Fam TC CCC
CAG GCA CTC CTT TCA AGA C Tamra 39. The endogenous
b-actin gene control primers were: forward: 59 CTG CCT GAC
GGC CAG GTC 39, reverse: 59 CAA GAA GGA AGG CTG
GAA AAG A 39, and probe: 59 Fam CA CTA TTG GCA ACG
AGC GGT TCC G Tamra 39. Relative differences of transgene
copy numbers were calculated using a standard dCt method with a
known amount of control plasmid.
Figure 2. T121 expression is induced in tissues of 2 month-old TgK19GT121; b-actin Cre mice by IHC. Strong brown staining indicates
positive T121 expression.
doi:10.1371/journal.pone.0080459.g002
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Figure 3. T121 expression is induced in tissues of 2-month old TgK18GT121; b-actin Cremice. A. T121 expression by IHC. Black arrows indicate
T121 positive cells. Scale bar = 50 mM. B. Double immunofluorescence staining of T121 as green and endogenous K18 as red in tissues shown as
merged confocal images. White arrows indicate intestinal epithelial cells positive for both endogenous K18 and T121. Scale bar = 25 mM.
doi:10.1371/journal.pone.0080459.g003
Table 1. Summary of histopathological findings in TgK19GT121; b-actin Cre and TgK18GT121; b-actin Cre mice.
Lesions TgK19GT121; b-actin Cre* (n=15, 6 m and 9 f) TgK18GT121; b-actin Cre* (n =10, 2 m and 8 f)
Lung bronchiole hyperplasia 15 (100%) 0
Intestine hyperplasia{ 15 (100%) 4 (40%)
Stomach, glandular foveolar cells hyperplasia 15 (100%) 0
Gallbladder epithelium hyperplasia 15 (100%) 0
Prostate hyperplasia and mPIN{ 6 (100%) 2 (100%)
Oviduct hyperplasia 9 (100%) N.D.
Kidney hydronephrosis 11(73%) 0
Liver bile ductule hyperplasia 10 (67%) 0
Ureter hyperplasia 9 (60%) N.D.
Urinary bladder hyperplasia{ 8 (53%) 1 (10%)
Mammary epithelium hyperplasia{ 4 (44%) 8 (100%)
Pancreatic ductal epithelium hyperplasia# 4 (27%) 0
Adrenal hyperplasia 3 (20%) 3 (30%)
Thymus hyperplasia{ 2 (13%) 10 (100%)
Uterus hyperplasia 1 (7%) 2 (20%)
Ovarian surface epithelium hyperplasia 4 (44%) 4 (50%)
*Average age of TgK19GT121; b-actin Cre mice analyzed here was 123 days (2–6 months, mainly line 43) and TgK18GT121; b-actin Cre mice 130 days (1–6 months, both
lines). Three TgK19GT121; b-actin Cre mice were euthanized due to kidney hydronephrosis at 2 months of age. All TgK18GT121; b-actin Cre mice were euthanized due to
thymic masses at 1–6 months of age.
{The onset and extent of lesions were different between TgK19GT121; b-actin Cre and TgK18GT121; b-actin Cre mice (see text for details).
#multifocal hyperplasia. m: male; f: female; N.D.: not determined.
doi:10.1371/journal.pone.0080459.t001
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Histopathology and Immunodetection
Transgenic tissues were dissected at indicated ages and fixed
overnight in 10% neutral buffered formalin, transferred to 70%
ethanol, routinely processed, and embedded in paraffin. Tissues
were sectioned for 10 successive layers at 5 mm intervals except
lymphoid tissues (4 mm) and stained with haematoxylin and eosin
(H&E) for histopathological examination. Immunohistochemistry
(IHC) and immunofluorescence (IF) analyses were performed on
formalin-fixed paraffin-embedded sections as previously described
[26]. Antibodies included: anti-K8/18 (1:500, guinea pig poly-
clonal, GP11, Progen Biotechnik, GMBH, Heidelberg, Germany),
anti-K19 (1:200, rabbit monoclonal, Epitomics, CA), anti-K14
(1:1000, rabbit polyclonal, pRB-155P, Covance), anti-GFP (1:500,
b-2, mouse monoclonal, Santa Cruz), anti-SV40 T antigen (1:100,
mouse monoclonal, DP02-200UG, Calbiochem), and anti-Ki-67
(1:500, rabbit polyclonal, 06-570, BD Pharmingen, San Diego,
CA). For double IF staining, the first primary antibody (anti-eGFP
or anti-SV40 T antigen) was incubated overnight followed by the
second primary antibody (anti-K19, anti-K14, or anti-K18)
incubation for 2 hours at room temperature. Mixed Alexa fluor
488 and 594 (1:200 dilution, Life Technologies) served as
secondary antibodies. Images were captured using light, immu-
nofluorescence, or Zeiss confocal microscopes. Apoptosis levels
were detected in sections using the terminal deoxynucleotidyl-
transferase-mediated dUTP-biotin nick end labeling (TUNEL)
assay (ApopTag Peroxidase In Situ Apoptosis Detection Kit, S7100
Millipore) following the manufacturer’s instruction [26]. To
quantify Ki-67 positive cells, random 5–10 Ki-67-positive fields
with the same magnification were acquired using a Zeiss
microscope, and Ki-67 positive and negative cells were counted
manually. Positivity was calculated as the average percentage of
total cells.
Statistical Analyses
Student t or Mann-Whitney rank sum tests were performed to
evaluate the statistical significance among genotypes and tissues.
P,0.05 was considered statistically significant.
Figure 4. Neoplastic lesions in TgK19GT121; b-actin Cre mice. Hyperplasia was observed in most tissues (lung and colon: indicated by black
arrows). Multifocal ductal hyperplasia was observed in pancreas, as well as mouse prostate intraepithelial neoplasia (mPIN) in prostate, and
hydronephrosis as indicated by white arrows in kidney. All samples were stained with H&E.
doi:10.1371/journal.pone.0080459.g004
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Results
Transgene Expression Accurately Reflects Epithelial
Subtype Specificity
To target RB-TS inactivation to epithelial subtypes, we
employed keratin regulation within BACs to drive conditional
transgene expression. A Cre-conditional loxP-eGFP-stop-loxP
(LSL) T121 cassette (Figure 1A) was introduced into the first exon
of either the K18 or the K19 gene within respective BACs to
generate TgK18GT121 and TgK19GT121 transgenic mice
(Figure 1B). Thus, eGFP was expressed under K18 or K19
regulation until expression/activation of Cre, which mediated
eGFP deletion and induced T121 expression. Two transmitting
founder lines for each construct were generated and characterized.
As assessed by quantitative real time PCR, mice harbored one
transgene copy in lines TgK19GT121-34 and -43, and TgK18GT121-
36, and 3 transgene copies in line TgK18GT121-34 (Figure 1C).
To detect endogenous K19 and K18 expression, and thus the
patterns for accurate transgene regulation, wild type epithelial
tissues were examined by IHC or IF. Consistent with reported
results [2,3,8], both K19 and K18 were widely expressed in a
variety of mouse epithelial tissues (Figure S1 and Table S1).
TgK18GT121 and TgK19GT121 eGFP transgene expression was
visualized in whole tissues using a stereo fluorescence microscope
(SteREO Discovery.V20, Carl Zeiss Meditec, Inc). Strong green
fluorescence was observed in some tissues of both lines of
TgK19GT121 mice (e.g. intestine, stomach, urinary bladder, and
gallbladder), but weak or no green fluorescence in others (e.g.
mammary gland, ovary, and pancreas, Figure S2). Many tissues
showed strong green fluorescence in both lines of TgK18GT121
mice (e.g. intestine, stomach, thymus, mammary gland, ovary,
salivary gland, urinary bladder and vas deferens, epididymis, and
gallbladder), but not in pancreas, lung, and liver (Figure S3). In
TgK19GT121 mice, immunostaining of tissue sections consistently
showed strong and widespread eGFP expression in intestine,
stomach, urinary bladder, gallbladder, and renal pelvis epithelium.
Readily detectable staining was limited to a smaller percentage of
cells in lung, mammary gland, and prostate (Figure S4 and Table
S1). Other tissues had very weak or no detectable eGFP expression
(Table S1). In TgK18GT121 mice, eGFP expression was widespread
in most K18-positive epithelial tissues (Figure S5 and Table S1).
Importantly, based on double IF, eGFP was co-expressed with
respective endogenous keratins in TgK19GT121 (Figure S4) and
TgK18GT121 mice (Figure S5), but excluded from K14 cells (Figure
Figure 5. Proliferation in T121-expressing TgK19GT121; b-actin Cre tissues. Proliferation was assessed by Ki-67 IHC (brown) in tissues of 2
months old mice. Arrows indicate ovarian surface epithelial cells (OSECs) positive for Ki-67. Scale bar = 50 mM.
doi:10.1371/journal.pone.0080459.g005
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S6). However, not all K19 or K18 positive cells expressed eGFP.
Both lines of TgK19GT121 mice showed similar eGFP expression.
Tissues from TgK18GT121-34 mice showed more intense eGFP
staining compared to those from TgK18GT121-36 mice (data not
shown), possibly due to the higher transgene copy number in line
34 (Figure 1C).
RB-TS Inactivation is Induced in Specific Epithelial
Subtypes
To determine whether T121 expression could be induced in a
broad range of epithelial tissues with subtype specificity and to
evaluate the effect of RB-TS inactivation, we crossed hemizygous
transgenic mice from all lines to transgenic b-actin Cre homozygous
mice. Likely due to broad RB-TS inactivation in K19 expressing
embryonic cells (see below), some embryonic lethality was
observed in TgK19GT121; b-actin Cre mice. Live-born bi-transgenic
mice were under-represented relative to littermate controls (34%
vs. 66% for TgK19GT121-34, 45% vs. 55% for TgK19GT121-43,
respectively; Table S2), suggesting that RB function in K19 cells
may be critical for development. In the surviving mice, consistent
with the breadth of endogenous K19 expression (Figure S1), T121
expression was readily observed in a variety of tissues first assessed
at 2 months of age (Figure 2), even though eGFP expression had
been low or below the IHC detection level in some of these tissues
(e.g. ovary, mammary gland and pancreas, Figures S2 and S4, and
Table S1). Importantly, as eGFP was faithfully expressed in K19
cells, T121 was also expressed in K19-positive cells (not shown), but
excluded from K14 cells (Figure S6). T121 expression levels were
comparable between TgK19GT121-34; b-actin Cre and TgK19GT121-
43; b-actin Cre mice (not shown).
Contrary to TgK19GT121; b-actin Cre mice, both lines of
TgK18GT121; b-actin Cre mice developed with normal Mendelian
frequencies (not shown). T121 was widely expressed in K18
expressing epithelium of some tissues of 2 month old TgK18GT121;
b-actin Cre mice (e.g. thymus, mammary gland, and ovary), but
showed limited induction in others, albeit in the appropriate cells
(e.g. intestine, prostate, and pancreas; Figure 3), even though
eGFP expression had been more widespread in some cases
(Figures S3 and S5, and Table S1). Importantly, T121 was
expressed in K18 positive cells (Figure 3B), but excluded from K14
cells (Figure S6). The intensity of T121 expression was comparable
between TgK18GT121-34; b-actin Cre and TgK18GT121-36; b-actin
Cre lines (not shown) although eGFP expression was higher in
TgK18GT121-34 than TgK18GT121-36 mice (not shown). This
observation may reflect somatic Cre-mediated copy number
reduction from a tandem gene array.
RB-TS Inactivation Causes Neoplasia
Compared to wildtype mice (Figure S7A), all TgK19GT121-43;
b-actin Cre mice developed multifocal hyperplastic lesions in most
K19 positive epithelial tissues [e.g. pancreas (pancreatic ductal
epithelium), mammary gland, ovary (ovarian surface epithelial
cells, OSECs), lung bronchiole, liver bile ductule, gallbladder,
kidney (renal pelvis epithelial cells), urinary bladder, prostate,
small intestine, colon, stomach glandular foveolar cells; Figure 4
and Table 1]. This phenotype was concurrent with high
proliferation rates in the affected cells (Figures 5 and 6) compared
to wildtype tissues (Figures 6 and S8). As in previous reports of
limited tissues [26,27,30], increased proliferation in tissues of
TgK19GT121; b-actin Cre mice was accompanied by a significant
elevation of apoptosis (Figure S9) compared to that of wildtype
mice (Figure S10). These results indicate that RB is important for
suppressing hyperplasia of K19 positive cells. Some TgK19GT121;
b-actin Cre mice developed life-threatening bilateral or unilateral
hydronephrosis starting as early as 2 months of age (Figure S11A).
The hydronephrosis was interpreted to be secondary to marked
hyperplasia of transitional cell epithelium at the junction of the
renal pelvis and ureter resulting in obstruction of urine outflow
from the kidney (Figure S11A). Other mice from line 34 had to be
euthanized due to enlarged thymuses, which led to life-
threatening thoracic pressure, at 7 months of age (Figure S11B).
Similar to TgK19GT121; b-actin Cre mice, inactivation of RB-TS
in K18-positive cells predominantly led to hyperplasia (Figure 7
and Table 1), which was correlated with T121 expression in these
tissues (Figure 3). With broad induction by the b-actin Cre allele,
both TgK18GT121-34 and TgK18GT121-36 mice developed severe
thymic epithelial hyperplasia and subsequent lymphoid hyperpla-
sia (Table 1 and Figure 7). Immunostaining indicated high T121
Figure 6. Proliferation rates in tissues of TgK19GT121; b-actin Cre and TgK18GT121; b-actin Cre mice. Proliferation rates of pancreas, mammary
gland, ovary, prostate (dorsolateral lobe), and bladder were quantified on tissue sections stained with Ki-67. *Significantly different from WT control
(p,0.001); #significantly different between TgK19GT121; b-actin Cre and TgK18GT121; b-actin Cre (p = 0.007); @ significantly different between
TgK18GT121; b-actin Cre and WT (p = 0.043).
doi:10.1371/journal.pone.0080459.g006
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expression in K18 cortical thymic epithelium (Figure S12B)
associated with high proliferation (based on Ki-67 IHC) and
apoptosis (TUNEL) rates (Figure S12C). Because these mice were
compromised due to life-threatening thoracic pressure from
enlarged thymuses (Figure S12A) and required euthanasia by 6
months of age, TgK18GT121; b-actin Cre phenotypes in other tissues
could not be examined past this age. At 1–6 months of age, mild
focal hyperplasia was observed in mammary gland, ovarian
surface epithelium, intestine, and prostate (Figure 7 and Table 1),
which correlated with elevated proliferation rates and increased
apoptosis (Figures 6, 8, and S13). For the most part, when
compared to TgK19GT121; b-actin Cre mice, the extent of
hyperplasia was less widespread in TgK18GT121; b-actin Cre mice,
which correlated with the limited extent of T121 expression in these
tissues. High proliferation rates were observed in both K19 and
K18 positive mammary epithelia and ovarian surface epithelia
(38.6% vs. 49.2% in mammary, and 51.2% vs. 34.2% in ovary,
respectively, Figure 6), which could be explained by co-expression
of K19 and K18 in these tissues (Figure S1). However, this is not
the case for other sites of co-expression (e.g. prostate, Figure 6),
suggesting that tissue-specificity may play a role in Cre recombi-
nation efficiencies.
Inactivation of RB-TS in Adult-restricted K19+ Cells is
Sufficient for Tumor Initiation
To circumvent the developmental defects observed in
TgK19GT121; b-actin Cre mice and to demonstrate the utility of
these models for studying cancer development in adult organs, we
crossed TgK19GT121-34 to tamoxifen-inducible K19CreER mice
[40]. In contrast to TgK19GT121; b-actin Cre mice,
TgK19GT121;K19CreER mice were born with expected Mendelian
frequencies (not shown), further supporting the critical role of RB-
TS in K19 positive cells during mouse development. Mice were
induced with tamoxifen at 6–8 weeks of age, and T121 expression
was assessed by IHC. T121 was first readily detectable in
gallbladder at 2 weeks post induction (not shown) and was
Figure 7. Neoplastic lesions in TgK18GT121; b-actin Cre mice. Hyperplasia was observed in some tissues (ovary and prostate: indicated by
arrows). All mice were euthanized at 1–7 months of age due to life-threatening thoracic pressure caused by enlarged thymuses. All samples were
stained with H&E.
doi:10.1371/journal.pone.0080459.g007
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Figure 8. Proliferation in T121-expressing TgK18GT121; b-actin Cre tissues. Proliferation was assessed as in Figure 5 in 2 month old mice. Similar
proliferation levels were observed in small intestine, colon, stomach and ovarian follicle as that of wildtype mice shown in Figure S8. Black arrows
indicate Ki-67 positive cells. Scale bar = 50 mM.
doi:10.1371/journal.pone.0080459.g008
Table 2. Summary of low grade lesions in tamoxifen-induced TgK19GT121-34;K19CreER mice.
Male (.9 mo PI) Female (.8 mo PI)
Lesions n (lesion/total) Frequency (%) n (lesion/total) Frequency (%)
Lung bronchiole hyperplasia 13/14 92.9 9/10 90.0
Colon GIN 11/12 91.7 10/10 100.0
Stomach (glandular) atypical hyperplasia 12/14 85.7 9/10 90.0
Kidney hydronephrosis 12/16 75.0 4/10 40.0
Prostate mPIN 10/16 62.5
Duodenum GIN 3/5 60.0 0/3 0
Gallbladder atypical hyperplasia 8/14 57.1 3/10 30.0
Cecum GIN 4/13 30.8 1/10 10.0
Urinary bladder atypical hyperplasia* 0/17 0 3/11 27.3
Histopathology was analyzed in males (9–14 months post induction (PI)) and females (8–16 months PI). GIN: gut intraepithelial neoplasia; mPIN: mouse prostate
intraepithelial neoplasia. mo: month.
*All males and 8 females developed high grade lesions (adenoma), which are summarized in Table 3.
doi:10.1371/journal.pone.0080459.t002
Epithelial Subtype-Dependent Cancer Initiation
PLOS ONE | www.plosone.org 9 December 2013 | Volume 8 | Issue 12 | e80459
widespread in various tissues by 4–6 weeks post induction (Figure
S14A). Moreover, T121 was co-expressed with K19 (Figure S14B).
Consistent with expression of eGFP prior to Cre expression, and,
typical of transgene expression, T121 was expressed in a subset of
K19 positive cells within a given tissue.
To determine whether RB-TS inactivation predisposed adult
K19-expressing epithelial cells to tumorigenesis, tamoxifen-in-
duced TgK19GT121;K19CreER mice were aged. Consistent with the
general hyperplastic phenotype observed in TgK19GT121; b-actin
Cre mice, a high frequency of atypical hyperplasia was observed in
most epithelial tissues (e.g. stomach glandular epithelium 85.7% in
males and 90% in females, and lung bronchiole epithelium 92.9%
in males and 90% in females; Table 2), consistent with increased
proliferation rates (not shown). While a low frequency of
malignant neoplasia did occur in some tissues (e.g. stomach
adenocarcinoma 13.3% in males and 14.3% in females; Table 3
and Figure 9), low grade lesions present in most organs indicated
that RB-TS inactivation was sufficient to initiate but not to
progress disease. This is consistent with our previous results in
mammary [27], prostate [26], choroid plexus [29] and ovarian
epithelium [28], and brain astrocytes [30,31]. Similar to
TgK19GT121; b-actin Cre mice, renal hydronephrosis was also
observed in 75% of males and 40% of females of induced
TgK19GT121;K19CreER mice at 9–16 months post induction
(Table 2). However, unlike TgK19GT121; b-actin Cre mice, the
cause of death was bladder obstruction due to high expression of
K19 in intermediate and basal cells of bladder epithelium (Figure
S7B) and a high frequency of adenoma development in the
bladder (Table 3 and Figure 9). Interestingly, we observed earlier
onset of urinary bladder adenoma in males compared to females (9
Table 3. Summary of neoplastic lesions developed in tamoxifen-induced TgK19GT121-34;K19CreER mice.
Male (.9 mo PI, n= 15) Female (.14 mo PI, n =7)
Lesions n Frequency (%) n Frequency (%)
Urinary bladder adenoma 15 100.0 5 71.4
Stomach (glandular) adenocarcinoma 2 13.3 1 14.3
Lung adenoma (alveolar/bronchiolar) 2 13.3 2 28.6
Renal papilloma/carcinoma 2 13.3 0 0
Ureter/urethra carcinoma 4 26.7 1* (8 mo PI) 14.3
Ureter adenoma 1 6.7 0 0
Males developed neoplastic lesions at 9 months post induction (PI), while females at 14 months PI except one at 8 months PI (*labeled). mo: month.
doi:10.1371/journal.pone.0080459.t003
Figure 9. Neoplastic lesions in tamoxifen-induced TgK19GT121; K19CreER tissues. Urinary bladder adenoma, lung adenoma, stomach
adenocarcinoma, renal carcinoma, and gut intraepithelial neoplasia (GIN), and mPIN lesions in prostate are shown at low and high magnifications.
Mild pancreatic duct hyperplasia was observed in pancreas as indicated by arrows. All samples were stained with H&E.
doi:10.1371/journal.pone.0080459.g009
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months vs. 14 months post induction; Table 3). The underlying
mechanism is unknown.
Discussion
Studies utilizing tissue-specific gene targeting in genetically
engineered mouse models have contributed extensively to our
understanding of cancer complexity and the molecular and
cellular basis of tumorigenesis. Here we describe the generation
of transgenic mouse models (TgK18GT121 and TgK19GT121) using
keratin gene transcriptional regulators to drive conditional
epithelial subtype-specific inactivation of RB-TS. High fidelity of
respective keratin-specific expression patterns was achieved using
BAC transgenes that were also engineered for assessing tissues of
interest via reporter GFP expression. We demonstrate that these
models can be used in combination with specific Cre drivers to
initiate tumorigenesis in a wide range of epithelial tissues in either
K19 or K18 expressing subtypes. We further demonstrate that
RB-TS inactivation can indeed elicit pre-cancerous lesions cell
autonomously in all tested epithelial tissues, including upon
induction strictly in adult organs, and that early neoplasia is
uniformly associated with aberrant proliferation and apoptosis.
Using subtype-specific targeting, a broad range of K18 or K19
positive subtypes within epithelial tissues were susceptible to
neoplastic induction by RB-TS inactivation. Neither TgK18GT121;
b-actin Cre mice (up to 6 months) nor TgK19GT121; b-actin Cre mice
(up to 8 months) developed adenomas or carcinomas. These
results confirm that RB-TS inactivation in affected epithelia only
initiates a neoplastic phenotype. Based on previous studies of
tumor progression in T121-initiated cells, we expect that additional
lesions in specific cancer genes will be required to drive this early
neoplastic phenotype into respective cancers. Indeed, we have
demonstrated this case using the K18-driven system in ovarian
surface epithelium, wherein lesions disrupting p53 function
facilitate progression to metastatic stage IV serous ovarian cancer
[28], and in mammary epithelium, where Trp53 and BRCA1
deletion progresses hyperplasia to adenocarcinoma (Van Dyke
et al., unpublished). Using the K19-driven system, we have also
observed that mammary hyperplasia can progress with additional
PTEN deletion (Song and Van Dyke et al., unpublished).
In comparing results from K18 and K19-driven models, most
tissues showed a potential subtype-dependency with respect to the
extent of hyperplasia/dysplasia. This observation was independent
of transgene insertion site, since the same results were obtained
regardless of the transgenic line within each genotype. However,
the interpretation that K18 and K19 expressing epithelial subtypes
are differentially responsive to RB-TS inactivation is confounded
by the differential transgene induction rate by b-actin Cre in K18
and K19-driven models. Indeed, the breadth of oncogene
expression, and possibly cellular levels, was directly correlated
with the extent of neoplasia induced. TgK19GT121; b-actin Cre
epithelial tissues showed wide spread T121 induction and
neoplasia, while T121 was induced only in a subset of cells in
most TgK18GT121; b-actin Cre tissues and resulted in minimal
neoplasia. This outcome may be due to tissue-dependent Cre
recombination efficiencies and/or to temporal differences in K18
and K19 expression onset, since not every TgK18GT121; b-actin Cre
tissue showed low T121 induction. Whatever the explanation, this
study could not distinguish susceptibility between K19 and K18
subtypes in most tissues. Mammary epithelium and ovarian
surface epithelium are exceptions to this outcome in that RB-TS
inactivation under both K18 and K19 regulation led to overt
hyperplasia due to co-expression of K18 and K19 in these tissues,
an outcome reflecting the expected endogenous keratin expression
patterns. Of note, the K18-driven model, in which limited
expression within specific cell populations can be induced, will
be valuable for cancer initiation studies, since this situation mimics
the limited stochastic initiation that is thought to occur in human
cancers. Furthermore, focal induction via viral Cre injection in
specific tissue might be the best approach to assess the adult
induction of RB-TS inactivation in K18 cells in tissues other than
thymic epithelium. Overall, these ‘‘GEM cancer-initiator’’ models
provide useful tools with which to further define tissue and cell-
specific mechanisms for carcinoma progression via engineered,
carcinogen-induced and/or spontaneous evolution.
Supporting Information
Figure S1 Endogenous K19 and K18 expression in
wildtype mice. A. Endogenous K19 (brown, Scale bar = 50 mM)
and K18 (red, Scale bar = 25 mM) expression was detected by
immunohistochemistry (IHC) and immunofluorescence (IF),
respectively. B. Endogenous K19 expression (brown) was detected
by IHC. Scale bar = 50 mM.
(TIF)
Figure S2 GFP expression in TgK19GT121 tissues. GFP
fluorescence was visualized using SteREO Discovery.V20 Zeiss
microscope. Indicated regions with grossly detectable expression
include colon, cecum, small intestine (purple arrow), stomach (*),
urinary bladder (blue arrow), vas deferens (white arrows), seminal
vesicle (red arrow), and gallbladder (1). Expression was not
observed by this method in prostate (#), liver (&), mammary
gland, ovary (), and pancreas (¤). Scale bar = 2000 mM.
(TIF)
Figure S3 GFP expression in TgK18GT121 tissues. GFP
fluorescence was observed in intestine (small intestine, cecum, and
colon), stomach (*), thymus, mammary gland, ovary, salivary
gland, urinary bladder (blue arrows), vas deferens (white arrows),
epididymis (yellow arrow), gallbladder (1), but not in prostate (#),
testis (gray arrow), pancreas, lung, and liver (&) using SteREO
Discovery.V20 Zeiss microscope.
(TIF)
Figure S4 Co-expression of transgenic GFP and endog-
enous K19 in TgK19GT121 tissues. GFP (green) and
endogenous K19 (red) were co-stained by IF and shown as
confocal merged images. Umbrella cells (*) in urinary bladder
epithelium were negative for K19 and GFP. Scale bar = 25 mM.
(TIF)
Figure S5 Co-expression of transgenic GFP and endog-
enous K18 in TgK18GT121 tissues. GFP (green) and
endogenous K18 (red) were co-stained by IF and shown as
confocal merged images. White arrows indicate ovarian surface
epithelial cells (OSECs), which co-expressed K18 and eGFP. Red
arrows indicate OSECs that are negative for transgenic eGFP, but
positive for endogenous K18, indicating mosaic expression typical
of transgenes and observed to varying extents in all tissues. Scale
bar = 25 mM.
(TIF)
Figure S6 Exclusion of transgene expression from K14
cells in mammary glands. K14 was double immunostained
with eGFP in TgK18GT121 and TgK19GT121 or T121 in
TgK18GT121; b-actin Cre and TgK19GT121; b-actin Cre mammary
glands. Dapi was used to counterstain nuclei. *indicates the high
background staining of eGFP in mammary glands of TgK19GT121
mice.
(TIF)
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Figure S7 Wildtype mouse tissue architecture. A. Histol-
ogy of wildtype tissues by H&E staining. B. Double immunostain-
ing of K19 and K18 or K19 and p63 in urinary bladder. White
arrows indicate umbrella cells negative for both K19 and p63.
Scale bar = 25 mM.
(TIF)
Figure S8 Proliferation in wildtype tissues. Proliferation
was assessed by Ki-67 IHC (brown) and was either low or
undetectable in most tissues. Normal small intestine, colon,
stomach, and ovarian follicle proliferation was readily detected.
Scale bar = 50 mM.
(TIF)
Figure S9 Apoptosis in T121-expressing TgK19GT121; b-
actin Cre tissues. Apoptosis (brown) was assessed by TUNEL in
tissues of 2 months old mice. Methyl green was used to
counterstain nuclei. Scale bar = 50 mM.
(TIF)
Figure S10 Apoptosis in wildtype tissues. Apoptosis,
evaluated as in Figure S9, was minimal in tissues of 2 months
old wildtype mice. Scale bar = 50 mM.
(TIF)
Figure S11 Renal and thymic phenotypes in
TgK19GT121; b-actin Cre mice. A. Left: Gross morphology
of unilateral hydronephrosis shows relative normal size of left
kidney and cystic right kidney; Middle: Histopathology of the renal
pelvis/ureter junction revealed by H&E staining; Right: prolifer-
ation of the renal pelvis/ureter junction by Ki-67 IHC. Marked
hyperplasia of transitional cell epithelium in the junction resulted
in obstruction of urine outflow from the kidney. Most mice were
euthanized due to hydronephrosis at 2–7 months. B. Some
TgK19GT121-34; b-actin Cre mice also developed life-threatening
thymic masses (left) at 7 months of age. Histopathology reveals
expansion of thymic epithelial and lymphoid compartments (right)
as observed routinely in TgK18GT121; b-actin Cre mice.
(TIF)
Figure S12 Thymic phenotype in TgK18GT121;b-actin
Cre mice. A. Kaplan-Meier survival curve analysis of both
TgK18GT121 lines crossed to b-actin Cre mice. B. T121 (green) was
highly induced and coexpressed with K18 (red) in thymus by IF
shown as confocal merged image. C. Proliferation and apoptosis
levels were assessed by Ki-67 and TUNEL, respectively, in
wildtype (WT) and TgK18GT121; b-actin Cre thymus.
(TIF)
Figure S13 Apoptosis in T121-expressing TgK18GT121; b-
actin Cre tissues. Apoptosis, evaluated as in Figure S9, was low
in most tissues of 2 months mice. Scale bar = 50 mM.
(TIF)
Figure S14 T121 induction via tamoxifen injection in
TgK19GT121;K19CreER mice. A. T121 (brown) was readily
detected in 4–6 weeks post induced tissues. Scale bar = 50 mM. B.
T121 (green) was co-expressed with endogenous K19 (red) by IF
and shown as confocal merged images. Scale bar = 25 mM.
(TIF)
Table S1 Summary of endogenous K18 and K19 expression in
wildtype mice, eGFP expression in TgK18GT121 and TgK19GT121







Table S2 Summary of live born pups from both lines of
TgK19GT121 heterozygous crossed to b-actin Cre homozygous mice.
(DOC)
Acknowledgments
The authors thank Anne Wolthusen, Daniel Roth, Shari Sweeney, and the
following UNC-Chapel Hill support: Laboratory Animal Medicine for
excellent animal care, Dr. JrGang Cheng in BAC Engineering Core
Facility for generating the keratin BAC constructs, the Histopathology
Core Facility for histopathological service, Dr. Virginia Godfrey at
Pathology & Lab Medicine for initial pathological evaluation of tissue
slides, Michael Hooker Microscopy Facility and Microscopy Services
Laboratory for confocal images. We thank the following in the Center for
Cancer Research (CCR) of NCI: Stephanie Henderson and the Mouse
Cancer Genetics transgenic core directed by Deborah A. Swing for
excellent animal care, and Linda Cleveland, Sophie Wang, and Jingyi
(Tina) Huang for technical assistance. We thank the following SAIC-
Frederick laboratories: Pathology/Histotechnology Laboratory for histo-
pathological service and the Optical Microscopy and Analysis Laboratory
directed by Dr. Stephen Lockett for confocal images. The authors thank
Dr. Guoqiang Gu (Vanderbilt University Medical Center, Nashville,
Tennessee) for providing K19CreER knock-in mice. We sincerely appreciate
Drs. Glenn Merlino, Shyam Sharan, Simone Difilippantonio, and Karl
Simin for critical reading of the manuscript.
Author Contributions
Conceived and designed the experiments: YS TVD. Performed the
experiments: YS DG TNO CY WP AF LL. Analyzed the data: YS TVD
DCH PLM. Contributed reagents/materials/analysis tools: TVD. Wrote
the paper: YS TVD.
References
1. Chu PG, Weiss LM (2002) Keratin expression in human tissues and neoplasms.
Histopathology 40: 403–439.
2. Omary MB, Ku NO, Strnad P, Hanada S (2009) Toward unraveling the
complexity of simple epithelial keratins in human disease. J Clin Invest 119:
1794–1805.
3. Moll R, Divo M, Langbein L (2008) The human keratins: biology and
pathology. Histochem Cell Biol 129: 705–733.
4. Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, et al. (2006)
New consensus nomenclature for mammalian keratins. J Cell Biol 174: 169–174.
5. Oshima RG, Howe WE, Klier FG, Adamson ED, Shevinsky LH (1983)
Intermediate filament protein synthesis in preimplantation murine embryos. Dev
Biol 99: 447–455.
6. Brulet P, Babinet C, Kemler R, Jacob F (1980) Monoclonal antibodies against
trophectoderm-specific markers during mouse blastocyst formation. Proc Natl
Acad Sci USA 77: 4113–4117.
7. Lu H, Hesse M, Peters B, Magin TM (2005) Type II keratins precede type I
keratins during early embryonic development. Eur J Cell Biol 84: 709–718.
8. Karantza V (2011) Keratins in health and cancer: more than mere epithelial cell
markers. Oncogene 30: 127–138.
9. Sherr CJ, McCormick F (2002) The RB and p53 pathways in cancer. Cancer
Cell 2: 103–112.
10. Viatour P, Sage J (2011) Newly identified aspects of tumor suppression by RB.
Dis Model Mech 4: 581–585.
11. Knudsen ES, Pajak TF, Qeenan M, McClendon AK, Armon BD, et al. (2012)
Retinoblastoma and phosphate and tensin homolog tumor suppressors: impact
on ductal carcinoma in situ progression. Journal of the National Cancer Institute
104: 1825–1836.
12. Gauthier ML, Berman HK, Miller C, Kozakeiwicz K, Chew K, et al. (2007)
Abrogated response to cellular stress identifies DCIS associated with subsequent
tumor events and defines basal-like breast tumors. Cancer Cell 12: 479–491.
13. Witkiewicz AK, Rivadeneira DB, Ertel A, Kline J, Hyslop T, et al. (2011)
Association of RB/p16-pathway perturbations with DCIS recurrence: depen-
dence on tumor versus tissue microenvironment. Am J Pathol 179: 1171–1178.
14. Reed CA, Mayhew CN, McClendon AK, Yang X, Witkiewicz A, et al. (2009)
RB has a critical role in mediating the in vivo checkpoint response, mitigating
secondary DNA damage and suppressing liver tumorigenesis initiated by
aflatoxin B1. Oncogene 28: 4434–4443.
15. Burkhart DL, Sage J (2008) Cellular mechanisms of tumour suppression by the
retinoblastoma gene. Nature Reviews Cancer 8: 671–682.
Epithelial Subtype-Dependent Cancer Initiation
PLOS ONE | www.plosone.org 12 December 2013 | Volume 8 | Issue 12 | e80459
16. Sharma A, Yeow WS, Ertel A, Coleman I, Clegg N, et al. (2010) The
retinoblastoma tumor suppressor controls androgen signaling and human
prostate cancer progression. J Clin Invest 120: 4478–4492.
17. Luo RX, Postigo AA, Dean DC (1998) Rb interacts with histone deacetylase to
repress transcription. Cell 92: 463–473.
18. Robanus-Maandag E, Dekker M, van der Valk M, Carrozza ML, Jeanny JC, et
al. (1998) p107 is a suppressor of retinoblastoma development in pRb-deficient
mice. Genes Dev 12: 1599–1609.
19. Dannenberg JH, van Rossum A, Schuijff L, te Riele H (2000) Ablation of the
retinoblastoma gene family deregulates G(1) control causing immortalization
and increased cell turnover under growth-restricting conditions. Genes Dev 14:
3051–3064.
20. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, et al. (2000) Targeted
disruption of the three Rb-related genes leads to loss of G(1) control and
immortalization. Genes Dev 14: 3037–3050.
21. DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, et al. (1989) The
product of the retinoblastoma susceptibility gene has properties of a cell cycle
regulatory element. Cell 58: 1085–1095.
22. Dyson N, Buchkovich K, Whyte P, Harlow E (1989) The cellular 107K protein
that binds to adenovirus E1A also associates with the large T antigens of SV40
and JC virus. Cell 58: 249–255.
23. Ewen ME, Ludlow JW, Marsilio E, DeCaprio JA, Millikan RC, et al. (1989) An
N-terminal transformation-governing sequence of SV40 large T antigen
contributes to the binding of both p110Rb and a second cellular protein,
p120. Cell 58: 257–267.
24. Stubdal H, Zalvide J, Campbell KS, Schweitzer C, Roberts TM, et al. (1997)
Inactivation of pRB-related proteins p130 and p107 mediated by the J domain
of simian virus 40 large T antigen. Mol Cell Biol 17: 4979–4990.
25. Sullivan CS, Tremblay JD, Fewell SW, Lewis JA, Brodsky JL, et al. (2000)
Species-specific elements in the large T-antigen J domain are required for
cellular transformation and DNA replication by simian virus 40. Mol Cell Biol
20: 5749–5757.
26. Hill R, Song Y, Cardiff RD, Van Dyke T (2005) Heterogeneous tumor evolution
initiated by loss of pRb function in a preclinical prostate cancer model. Cancer
Res 65: 10243–10254.
27. Simin K, Wu H, Lu L, Pinkel D, Albertson D, et al. (2004) pRb inactivation in
mammary cells reveals common mechanisms for tumor initiation and
progression in divergent epithelia. PLoS Biol 2: E22.
28. Szabova L, Yin C, Bupp S, Guerin TM, Schlomer JJ, et al. (2012) Perturbation
of Rb, p53 and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial
ovarian cancer. Cancer Res 72: 13.
29. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, et al. (1994) p53-
dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:
703–711.
30. Xiao A, Wu H, Pandolfi PP, Louis DN, Van Dyke T (2002) Astrocyte
inactivation of the pRb pathway predisposes mice to malignant astrocytoma
development that is accelerated by PTEN mutation. Cancer Cell 1: 157–168.
31. Simin K, Hill R, Song Y, Zhang Q, Bash R, et al. (2005) Deciphering cancer
complexities in genetically engineered mice. Cold Spring Harb Symp Quant
Biol 70: 283–290.
32. Chen J, Tobin GJ, Pipas JM, Van Dyke T (1992) T-antigen mutant activities
in vivo: roles of p53 and pRB binding in tumorigenesis of the choroid plexus.
Oncogene 7: 1167–1175.
33. Song Y, Zhang Q, Kutlu B, Difilippantonio S, Bash R, et al. (2013) Evolutionary
etiology of high-grade astrocytomas. Proc Natl Acad Sci USA 2013; published
ahead of print October 10, 2013.
34. Kumar P, Mukherjee M, Johnson JP, Patel M, Huey B, et al. (2012)
Cooperativity of Rb, Brca1, and p53 in malignant breast cancer evolution.
PLoS Genet 8: e1003027.
35. Pipas JM, Peden KW, Nathans D (1983) Mutational analysis of simian virus 40
T antigen: isolation and characterization of mutants with deletions in the T-
antigen gene. Mol Cell Biol 3: 203–213.
36. Sullivan CS, Pipas JM (2002) T antigens of simian virus 40: molecular
chaperones for viral replication and tumorigenesis. Microbiol Mol Biol Rev 66:
179–202.
37. Copeland NG, Jenkins NA, Court DL (2001) Recombineering: a powerful new
tool for mouse functional genomics. Nat Rev Genet 2: 769–779.
38. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, et al. (2001) A
highly efficient Escherichia coli-based chromosome engineering system adapted
for recombinogenic targeting and subcloning of BAC DNA. Genomics 73: 56–
65.
39. Yan C, Costa RH, Darnell JE, Jr., Chen JD, Van Dyke TA (1990) Distinct
positive and negative elements control the limited hepatocyte and choroid plexus
expression of transthyretin in transgenic mice. EMBO J 9: 869–878.
40. Means AL, Xu Y, Zhao A, Ray KC, Gu G (2008) A CK19CreERT knockin
mouse line allows for conditional DNA recombination in epithelial cells in
multiple endodermal organs. Genesis 46: 318–323.
Epithelial Subtype-Dependent Cancer Initiation
PLOS ONE | www.plosone.org 13 December 2013 | Volume 8 | Issue 12 | e80459
